流感相关曲霉病:2005至2014年全国趋势、预测因素与结局
该回顾性队列研究利用2005至2014年美国全国住院患者样本数据库,识别出477,556例以流感为主要诊断的住院患者,其中823例(0.17%)诊断为流感相关曲霉病(IAA)。与无IAA的流感住院患者相比,IAA队列死亡率更高(20.58% vs 1.36%),平均住院时间更长(17.94 vs 4.05天),人均住院费用更高(194,932 vs 24,286美元),P < .005。实体器官移植、血液系统恶性肿瘤及有创机械通气与IAA诊断几率升高相关。在IAA队列中,有创机械通气(调整OR 13.43)、更长住院时间(调整OR 5.47)、使用体外膜氧合(调整OR 4.99)及45-64岁年龄组(调整OR 3.03)与更高的院内死亡率相关。
要点
- 流感住院患者中IAA发生率0.17%(823/477,556),但院内死亡率高达20.58%,显著高于无IAA的1.36%。
- IAA患者平均住院时间17.94天 vs 无IAA者4.05天,人均费用194,932美元 vs 24,286美元(P < .005)。
- 实体器官移植、血液系统恶性肿瘤及有创机械通气与IAA诊断几率升高相关。
- 在IAA队列中,有创机械通气(调整OR 13.43)、更长住院时间(调整OR 5.47)、ECMO使用(调整OR 4.99)及45-64岁(调整OR 3.03)与院内死亡风险升高相关。
- 流感与IAA住院数随时间增加,2009年甲型H1N1流感大流行年达峰值。
适用人群与场景
- 2005至2014年美国全国住院患者样本数据库中,以流感为主要诊断的住院患者(共477,556例)。
- IAA队列更常见于45-65岁、城市教学医院、有药物滥用者。
研究设计与关键结果
- 回顾性队列研究,使用2005至2014年全国住院患者样本数据库,共识别477,556例流感住院,其中823例(0.17%)为IAA。
- IAA队列 vs 无IAA流感队列:院内死亡率20.58% vs 1.36%,平均住院时间17.94天 vs 4.05天,人均费用194,932美元 vs 24,286美元(P < .005)。
- 与IAA诊断几率升高相关的因素包括实体器官移植、血液系统恶性肿瘤及有创机械通气使用等。
- IAA队列中与院内死亡风险升高相关的因素:有创机械通气(调整OR 13.43;P < .005)、更长住院时间(调整OR 5.47;P < .005)、ECMO使用(调整OR 4.99;P = .014)、45-64岁年龄组(调整OR 3.03;P = .012)。
- 流感与IAA住院数均随时间增加,2009年甲型H1N1流感大流行年达峰值。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于流感住院患者,尤其是实体器官移植、血液系统恶性肿瘤或需要有创机械通气者,应警惕IAA可能,因其与死亡率、住院时间和费用显著增加相关。
- 在IAA患者中,需要有创机械通气、ECMO或住院时间延长提示院内死亡风险高。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Influenza-associated aspergillosis (IAA) has been increasingly reported in the literature in recent years, but contemporary large-scale data on the morbidity and mortality burden of IAA are lacking.
RESEARCH QUESTION: The goal of this study was to estimate the predictors, associations, and outcomes of IAA in the United States.
STUDY DESIGN AND METHODS: This retrospective cohort study was performed by using the National (Nationwide) Inpatient Sample database from 2005 to 2014 to identify influenza and IAA hospitalizations. Baseline variables and outcomes were compared between influenza hospitalizations without IAA and those with IAA. These variables were then used to perform an adjusted analysis for obtaining predictors and associations of the diagnosis and in-hospital mortality of IAA.
RESULTS: Of the 477,556 hospitalizations identified with the principal diagnosis of influenza, IAA was identified in 823 (0.17%) hospitalizations. The IAA cohort consisted more commonly of 45- to 65-year-olds in urban teaching hospitals with substance abuse. Yearly trends revealed that both influenza and IAA hospitalizations have increased over time, with a peak observed in 2009, the year of the influenza A(H1N1) pandemic. Mortality was higher (20.58% vs 1.36%), average length of stay was longer (17.94 vs 4.05 days), and mean cost per hospitalization was higher ($194,932 vs $24,286) in the IAA cohort compared with the influenza cohort without IAA (P < .005). Solid-organ transplantation, hematologic malignancies, and use of invasive mechanical ventilation were associated with higher odds of IAA, among other factors. Use of invasive mechanical ventilation (adjusted OR, 13.43; P < .005), longer length of stay (adjusted OR, 5.47; P < .005), utilization of extracorporeal membrane oxygenation (adjusted OR, 4.99; P = .014), and the group aged 45 to 64 years (adjusted OR, 3.03; P = .012) were associated with higher in-hospital mortality in the IAA cohort.
INTERPRETATION: Although IAA is a rare complication of influenza hospitalizations, it is associated with increased all-cause mortality, more extended hospital stays, and higher hospital charges compared with influenza without IAA.
参考来源
- Sharma A, Mishra T, Kumar N, et al. Influenza-Associated Aspergillosis: Nationwide Trends, Predictors and Outcomes From 2005 to 2014. Chest. 2020. PMID: 32565269. doi:10.1016/j.chest.2020.06.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。